MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Phlorizin

CAS No. : 60-81-1

MCE 国际站：Phlorizin

产品活性：Phlorizin (Floridzin) 是一种非选择性的 SGLT 抑制剂，对于 hSGLT1 和 hSGLT2 的 K_i 值分别为 300 和 39 nM。Phlorizin 也是一个 Na⁺/K⁺-ATPase 抑制剂。

研究领域：Membrane Transporter/Ion Channel

作用靶点：SGLT  |  Na+/K+ ATPase

结构分类：黄酮类  |  二氢查耳酮  |  酚类  |  多酚类  |  结构分类

来源：植物  |  蔷薇科  |  苹果

In Vitro: Phlorizin is a non-selective SGLT inhibitor with K_is of 300 and 39 nM for hSGLT1 and hSGLT2, respectively. Phlorizin is also a Na⁺/K⁺-ATPase inhibitor. Phlorizin at 2×10^-4 M inhibits Na⁺ and Rb⁺-activated ATPase activities in human red cell membranes by 43 %. At 1 mM and 7 mM RbCl, rubidium uptake is not changed or is slightly inhibited (less than 15 %) by 2×10^-4 M Phlorizin. Cell viability is not significantly altered by doses of Phlorizin <100 μM. Pretreating cells with Phlorizin does not significantly reduce nitrite or PGE₂ levels. Phlorizin does not suppress IL-6 or TNF-α production, although 100 μM Phlorizin can significantly inhibit TNF-α expression.

In Vivo: Prior to Phlorizin treatment, the blood glucose level in SDT fatty rats is 370±49 mg/dL. Six hours after dosing, the blood glucose level in the Phlorizin treated group decreases to an almost normal level (139±32 mg/dL). Phlorizin-treated SDT fatty rats are heavier than vehicle-treated SDT fatty rats after 12 weeks. Phlorizin treatment significantly decreases glucose excretion and delays insulin decreases. Creatinine clearance decreases significantly with Phlorizin treatment. 23 weeks of Phlorizin treatment prevents the decrease of nerve fibers (23.6±3.2 fibers/mm). Retinal abnormalities are completely prevented with Phlorizin.

相关产品：Natural Product Library Plus  |  Bioactive Compound Library Plus  |  Membrane Transporter/Ion Channel Compound Library  |  Natural Product Library  |  Anti-diabetic Compound Library  |  Glycoside Compound Library  |  Medicine Food Homology Compound Library  |  Phenols Library  |  Traditional Chinese Medicine Active Compound Library  |  Flavonoids Library  |  Anti-Cancer Metabolism Compound Library  |  Anti-Obesity Compound Library  |  Food-Sourced Compound Library   |  Plant-Sourced Natural Product Library  |  Human Metabolite Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  Highly Selective Inhibitors Library  |  Oleic acid-¹³C  |  Mizagliflozin  |  Chlorpropamide  |  Licogliflozin  |  Velagliflozin proline  |  (+)-SJ733  |  HSK0935  |  Prilocaine-d₇ hydrochloride  |  Ipragliflozin (L-Proline)  |  Tofogliflozin  |  Enavogliflozin  |  Oleic acid-¹³C-1  |  Remogliflozin etabonate  |  T-1095  |  Empagliflozin-d₄  |  Deslanoside  |  Citreoviridin  |  Digitoxin  |  SGL5213  |  Oleic acid-d₂  |  Stauntosaponin A  |  Dapagliflozin  |  Marinobufogenin  |  Sodium oleate  |  Oxonol VI  |  Annonacin  |  Oleic acid-d₉  |  Sotagliflozin

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物  |  寡核苷酸  |  抗体  |  点击化学

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

品牌介绍:
•   MCE (MedChemExpress) 拥有200 多种全球独家化合物库，我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物；
•   50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领；
•   产品种类涵盖各种重组蛋白，多肽，常用试剂盒 ，更有 PROTAC、ADC 等特色产品，广泛应用于新药研发、生命科学等科研项目；
•   提供虚拟筛选，离子通道筛选，代谢组学分析检测分析，药物筛选等专业技术服务；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
•   专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。